Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients.

Human vaccines & immunotherapeutics - 1 Dec 2026

Pruski Dominik, Millert-Kalińska Sonja, Żurawski Jakub, Jach Robert, Przybylski Marcin

Abstract excerpt

BACKGROUND: Human papillomavirus (HPV) infection remains the most prevalent sexually transmitted viral infection worldwide and a major etiologic factor for cervical and other anogenital cancers. HPV-related precancerous lesions continue to represent a substantial clinical and epidemiological burden. OBJECTIVE: We aim to assess the effects of nine-valent HPV vaccination on viral clearance, genotype distribution,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Human Papillomavirus Viruses
Share to Papillomaviridae

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Papillomavirus Infections

Share to Papillomavirus Vaccines

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Share to Vaccination

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 42047045
DOI: 10.1080/21645515.2026.2664310
PMCID: PMC13134422

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of the HPV vaccine in a group of primarily unvaccinated HPV-positive patients.PMID 42047045Read ↗

Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.Semantic proximity Read ↗

The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.Semantic proximity Read ↗

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.Semantic proximity Read ↗

HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.Semantic proximity Read ↗

Human Papilloma Virus Genotypes Associated with Non-Cervical HPV Positive Cancer Development in UK and Ireland Cohorts: A Systematic ReviewSemantic proximity Read ↗

Postvaccination prevalence of vaccine-Human Papillomavirus (vHPV) genotypes among the target population: A systematic review and meta-analysis.Semantic proximity Read ↗

Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013.Semantic proximity Read ↗

Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.Semantic proximity Read ↗

Reduction in Vaccine-Type Human Papillomavirus Prevalence Among Women in the United States, 2009-2012.Semantic proximity Read ↗

Prevalence of Vaccine-Covered and Non-Covered HPV Genotypes Among Unvaccinated Women in Ankara: A Single-Center StudySemantic proximity Read ↗

Human papillomavirus vaccination: the population impactSemantic proximity Read ↗

Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.